Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The role of postoperative concurrent chemotherapy (CCT) has not been established for salivary
gland tumors (SGTs). This prospective study was conducted to evaluate the feasibility and
safety of customized CCT regimens based on the gene targets of SGTs.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University